Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05110014 · ClinicalTrials.gov registry record · NA
Substudy of Protocol NCT03843957 - Effect of mPATH on Screening for Depression, Fall Risk, and Safety
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 23,026
- Enrollment target
NCT05110014: Completed NA study, sponsored by Wake Forest University Health Sciences.
NCT05110014 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 23,026 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1541% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05110014, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 23,026 participants
- Enrollment target
Study Summary
This is a sub-study for data analysis of data collected as part of the larger randomized controlled trial "Effectiveness and Implementation of mPATH-CRC" (NCT03843957) to determine if self-administered screening with an iPad increases the detection of patients with depression, falls, and intimate partner violence.
Primary Outcome
The primary outcome will be the proportion of patients seen in each time period ("pre" vs. "post") who screen positive for depression, fall risk, or intimate partner violence. The "pre" time period will be Days -60 to -1 (the 60 day period before mPATH Launch). Screening positive for depression will be a score of 3 or greater on the Patient Health Questionnaire-2. Screening positive for fall risk will be answering "yes" to having a device to assist with mobility and/or having fallen in the last
Interventions
- OTHER Primary Care Office Visits
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23,026 participants |
| Start Date | 2019-06-24 |
| Est. Completion | 2020-02-27 |
| Phase | NA |
What the finished NCT05110014 record still lists
NCT05110014 is an interventional study that assigns participants to a tested intervention. Its 23,026 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1541% higher).
The record links to 0 conditions, and to 1 intervention - of which Primary Care Office Visits is the first listed.
NCT05110014 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05110014 about?
NCT05110014 is a clinical study titled "Substudy of Protocol NCT03843957 - Effect of mPATH on Screening for Depression, Fall Risk, and Safety". This is a sub-study for data analysis of data collected as part of the larger randomized controlled trial "Effectiveness and Implementation of mPATH-CRC" (NCT03843957) to determine if self-administered screening with an iPad increases the detection of patients with depression, falls, and intimate pa...
What is the current status of trial NCT05110014?
This trial is currently completed. It is a NA study. The enrollment target is 23,026 participants. The study started on 2019-06-24. Estimated completion is 2020-02-27.
What interventions are being tested in trial NCT05110014?
The interventions under investigation include: Primary Care Office Visits (OTHER).
Who is sponsoring clinical trial NCT05110014?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05110014's enrollment target sits among peer trials
23,026 10th of 2000 higher than 1,991 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06486688 · 22,320 participants · NA
Centralized Virtual SBIRT for Pediatric Primary Care
- NCT07413211 · 22,068 participants
Genetic Developmental and Epileptic Encephalopathy Natural History Study for Clinical Trial Readiness
- NCT06995898 · 24,000 participants · NA
The Vanguard Study: Testing a New Way to Screen for Cancer
- NCT05488080 · 22,032 participants · NA
PAINED: Project Addressing INequities in the Emergency Department
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI